gc3111
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 14, 2019 (NCT04238975)
Timeline
Indications
Mechanism of action
- Tetanus toxinImmunity, active
tetX immunity, active
- Bordetella pertussisImmunity, active
Bordetella pertussis immunity, active
- Diphtheria toxinImmunity, active
Diphtheria toxin immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06997627 | Phase 1/Phase 2 (Phase 2) | Jun 5, 2025 | Green Cross Corporation |
| NCT04238975 | Phase 2 | Oct 14, 2019 | Green Cross Corporation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Green Cross Corporation | For profit | 2 | 2 | 1 | 2019 |
1 organizations
Page 1 / 1